lifestyle.sourcefed.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Editas Medicine, Inc.
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
March 27, 2026
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
March 9, 2026
Editas Medicine to Participate in Upcoming Investor Conferences
February 23, 2026